MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 208 filers reported holding MIRATI THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.22 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,682,357 | -75.6% | 46,564 | -74.9% | 0.01% | -94.2% |
| Q1 2023 | $6,888,710 | +261.1% | 185,280 | +340.1% | 0.10% | +197.1% |
| Q4 2022 | $1,907,460 | +763.1% | 42,098 | +1464.4% | 0.04% | +483.3% |
| Q1 2022 | $221,000 | -92.9% | 2,691 | -87.2% | 0.01% | -93.8% |
| Q4 2021 | $3,095,000 | +438.3% | 21,096 | +372.8% | 0.10% | +159.5% |
| Q4 2019 | $575,000 | -19.2% | 4,462 | -35.5% | 0.04% | -52.6% |
| Q2 2019 | $712,000 | -35.3% | 6,920 | -53.9% | 0.08% | -56.9% |
| Q1 2019 | $1,100,000 | – | 15,000 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 1,000,000 | $31,470,000 | 8.67% |
| Baker Brothers Advisors | 2,805,074 | $88,276,000 | 0.77% |
| Broadfin Capital, LLC | 359,661 | $11,319,000 | 0.61% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 397,660 | $12,514,000 | 0.42% |
| Boulegeris Investments, Inc. | 17,415 | $548,000 | 0.39% |
| SPHERA FUNDS MANAGEMENT LTD. | 95,000 | $2,990,000 | 0.29% |
| Rhenman & Partners Asset Management AB | 50,000 | $1,574,000 | 0.19% |
| Integre Asset Management, LLC | 23,996 | $755,000 | 0.16% |
| Orbimed Advisors | 680,500 | $21,415,000 | 0.16% |
| EAM Investors, LLC | 38,754 | $1,220,000 | 0.14% |